These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 32637482)

  • 21. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton MRS in twin pairs discordant for schizophrenia.
    Lutkenhoff ES; van Erp TG; Thomas MA; Therman S; Manninen M; Huttunen MO; Kaprio J; Lönnqvist J; O'Neill J; Cannon TD
    Mol Psychiatry; 2010 Mar; 15(3):308-18. PubMed ID: 18645571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the metabolic alterations in a depressive-like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T.
    Yoo CH; Lim SI; Song KH; Woo DC; Choe BY
    Neurochem Int; 2018 Jun; 116():22-29. PubMed ID: 29530754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.
    Hermens DF; Naismith SL; Chitty KM; Lee RS; Tickell A; Duffy SL; Paquola C; White D; Hickie IB; Lagopoulos J
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):836-45. PubMed ID: 25795519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.
    Théberge J; Al-Semaan Y; Williamson PC; Menon RS; Neufeld RW; Rajakumar N; Schaefer B; Densmore M; Drost DJ
    Am J Psychiatry; 2003 Dec; 160(12):2231-3. PubMed ID: 14638596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term effect of erythropoiesis stimulating agents given to preterm infants: a proton magnetic resonance spectroscopy study on neurometabolites in early childhood.
    Gasparovic C; Caprihan A; Yeo RA; Phillips J; Lowe JR; Campbell R; Ohls RK
    Pediatr Radiol; 2018 Mar; 48(3):374-382. PubMed ID: 29335880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensorimotor cortex neurometabolite levels as correlate of motor performance in normal aging: evidence from a
    Levin O; Weerasekera A; King BR; Heise KF; Sima DM; Chalavi S; Maes C; Peeters R; Sunaert S; Cuypers K; Van Huffel S; Mantini D; Himmelreich U; Swinnen SP
    Neuroimage; 2019 Nov; 202():116050. PubMed ID: 31349070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.
    Davanzo P; Yue K; Thomas MA; Belin T; Mintz J; Venkatraman TN; Santoro E; Barnett S; McCracken J
    Am J Psychiatry; 2003 Aug; 160(8):1442-52. PubMed ID: 12900307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
    Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
    Abbott C; Bustillo J
    Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI.
    Tumati S; Opmeer EM; Marsman JC; Martens S; Reesink FE; De Deyn PP; Aleman A
    Front Aging Neurosci; 2018; 10():106. PubMed ID: 29706886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocampal Neurometabolite Changes in Hypothyroidism: An In Vivo (1) H Magnetic Resonance Spectroscopy Study Before and After Thyroxine Treatment.
    Singh S; Rana P; Kumar P; Shankar LR; Khushu S
    J Neuroendocrinol; 2016 Sep; 28(9):. PubMed ID: 27203419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
    Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E
    Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of
    Das TK; Dey A; Sabesan P; Javadzadeh A; Théberge J; Radua J; Palaniyappan L
    Front Psychiatry; 2018; 9():438. PubMed ID: 30298023
    [No Abstract]   [Full Text] [Related]  

  • 39. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
    Théberge J; Bartha R; Drost DJ; Menon RS; Malla A; Takhar J; Neufeld RW; Rogers J; Pavlosky W; Schaefer B; Densmore M; Al-Semaan Y; Williamson PC
    Am J Psychiatry; 2002 Nov; 159(11):1944-6. PubMed ID: 12411236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
    Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
    Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.